Mohammed Ali, Z.; Fernández-Alarcón, B.; Fontova, P.; Vidal-Alabró, A.; Rigo-Bonnin, R.; Melilli, E.; Montero, N.; Manonelles, A.; Coloma, A.; Favà , A.;
et al. Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study. Pharmaceutics 2025, 17, 1185.
https://doi.org/10.3390/pharmaceutics17091185
AMA Style
Mohammed Ali Z, Fernández-Alarcón B, Fontova P, Vidal-Alabró A, Rigo-Bonnin R, Melilli E, Montero N, Manonelles A, Coloma A, Favà A,
et al. Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study. Pharmaceutics. 2025; 17(9):1185.
https://doi.org/10.3390/pharmaceutics17091185
Chicago/Turabian Style
Mohammed Ali, Zeyar, Beatriz Fernández-Alarcón, Pere Fontova, Anna Vidal-Alabró, Raul Rigo-Bonnin, Edoardo Melilli, Nuria Montero, Anna Manonelles, Ana Coloma, Alexandre Favà ,
and et al. 2025. "Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study" Pharmaceutics 17, no. 9: 1185.
https://doi.org/10.3390/pharmaceutics17091185
APA Style
Mohammed Ali, Z., Fernández-Alarcón, B., Fontova, P., Vidal-Alabró, A., Rigo-Bonnin, R., Melilli, E., Montero, N., Manonelles, A., Coloma, A., Favà , A., Grinyó, J. M., Cruzado, J. M., Colom, H., & Lloberas, N.
(2025). Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study. Pharmaceutics, 17(9), 1185.
https://doi.org/10.3390/pharmaceutics17091185
